✦ LIBER ✦

Efficacy, safety and tolerability of atorvastatin in dyslipidemic subjects with advanced (non-nephrotic) and endstage chronic renal failure

✍ Scribed by David Saltissi; Justin Westhuyzen; Colleen Morgan; Helen Healy

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

M.643 Efficacy, safety and tolerability

✍ Saltissi, D.; Morgan, C.; Westhuyzen, J. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 145 KB

Safety and efficacy of erythropoietin in

✍ John R. Brandt; Ellis D. Avner; Robert O. Hickman; S. L. Watkins 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 50 KB

Efficacy, safety and tolerability of met

✍ Prakash C. Deedwania; Thomas D. Giles; Michael Klibaner; Jalal K. Ghali; Johan H 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 202 KB

Open label non comparative study of the

✍ J. Páez; L. Alvarado; D. Toral; B. Delgado 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 247 KB

Clinical Efficacy and Safety of Recombin

✍ John F. Randolph; Janet Scarlett; Tracy Stokol; James N. MacLeod 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB

Plerixafor for PBSC mobilisation in myel

✍ Douglas, K W; Parker, A N; Hayden, P J; Rahemtulla, A; D'Addio, A; Lemoli, R M; 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 297 KB